Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Nonkululeko. Ndabambi"'
Autor:
Nonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, Rebecca T van Dorsten, Amanda S Woodward Davis, Nicolas Beaume, David Matten, Bronwen Lambson, Tandile Modise, Prudence Kgagudi, Talita York, Dylan H Westfall, Elena E Giorgi, Bette Korber, Colin Anthony, Rutendo E Mapengo, Valerie Bekker, Elizabeth Domin, Amanda Eaton, Wenjie Deng, Allan DeCamp, Yunda Huang, Peter B Gilbert, Asanda Gwashu-Nyangiwe, Ruwayhida Thebus, Nonkululeko Ndabambi, Dieter Mielke, Nyaradzo Mgodi, Shelly Karuna, Srilatha Edupuganti, Michael S Seaman, Lawrence Corey, Myron S Cohen, John Hural, M Juliana McElrath, James I Mullins, David Montefiori, Penny L Moore, Carolyn Williamson, Lynn Morris
Publikováno v:
PLoS Pathogens, Vol 19, Iss 6, p e1011469 (2023)
The VRC01 Antibody Mediated Prevention (AMP) efficacy trials conducted between 2016 and 2020 showed for the first time that passively administered broadly neutralizing antibodies (bnAbs) could prevent HIV-1 acquisition against bnAb-sensitive viruses.
Externí odkaz:
https://doaj.org/article/1a870a5047ec41f0af5508300c65082a
Autor:
Raabya Rossenkhan, Morgane Rolland, Jan P.L. Labuschagne, Roux-Cil Ferreira, Craig A. Magaret, Lindsay N. Carpp, Frederick A. Matsen IV, Yunda Huang, Erika E. Rudnicki, Yuanyuan Zhang, Nonkululeko Ndabambi, Murray Logan, Ted Holzman, Melissa-Rose Abrahams, Colin Anthony, Sodsai Tovanabutra, Christopher Warth, Gordon Botha, David Matten, Sorachai Nitayaphan, Hannah Kibuuka, Fred K. Sawe, Denis Chopera, Leigh Anne Eller, Simon Travers, Merlin L. Robb, Carolyn Williamson, Peter B. Gilbert, Paul T. Edlefsen
Publikováno v:
Viruses, Vol 11, Iss 7, p 607 (2019)
Knowledge of the time of HIV-1 infection and the multiplicity of viruses that establish HIV-1 infection is crucial for the in-depth analysis of clinical prevention efficacy trial outcomes. Better estimation methods would improve the ability to charac
Externí odkaz:
https://doaj.org/article/33758c334a41459d956b37f9c6fa6c7c
Autor:
Constantinos Kurt Wibmer, Jason Gorman, Gabriel Ozorowski, Jinal N Bhiman, Daniel J Sheward, Debra H Elliott, Julie Rouelle, Ashley Smira, M Gordon Joyce, Nonkululeko Ndabambi, Aliaksandr Druz, Mangai Asokan, Dennis R Burton, Mark Connors, Salim S Abdool Karim, John R Mascola, James E Robinson, Andrew B Ward, Carolyn Williamson, Peter D Kwong, Lynn Morris, Penny L Moore
Publikováno v:
PLoS Pathogens, Vol 13, Iss 1, p e1006074 (2017)
A comprehensive understanding of the regions on HIV-1 envelope trimers targeted by broadly neutralizing antibodies may contribute to rational design of an HIV-1 vaccine. We previously identified a participant in the CAPRISA cohort, CAP248, who develo
Externí odkaz:
https://doaj.org/article/fafbd70b5ca04c4ebf509176d6bdfa3b
Autor:
Denis R Chopera, Jaclyn K Mann, Philip Mwimanzi, Saleha Omarjee, Xiaomei T Kuang, Nonkululeko Ndabambi, Sarah Goodier, Eric Martin, Vivek Naranbhai, Salim Abdool Karim, Quarraisha Abdool Karim, Zabrina L Brumme, Thumbi Ndung'u, Carolyn Williamson, Mark A Brockman, CAPRISA 004 TRAPS Team
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71758 (2013)
Use of antiretroviral-based microbicides for HIV-1 prophylaxis could introduce a transmission barrier that inadvertently facilitates the selection of fitter viral variants among incident infections. To investigate this, we assessed the in vitro funct
Externí odkaz:
https://doaj.org/article/0beb17d4573a4c7a973a67afa52ef387
Autor:
Nonkululeko. Ndabambi, Jonathan M. Carlson, Salim S. Abdool Karim, Quarraisha Abdool Karim, Nobubelo K. Ngandu, D. Chopera, Carolyn Williamson
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Background: Women in the CAPRISA 004 trial assigned to use 1% tenofovir (TFV) microbicide gel, who became HIV-1 infected, had higher viral load set-point and slower antibody avidity maturati
Background: Women in the CAPRISA 004 trial assigned to use 1% tenofovir (TFV) microbicide gel, who became HIV-1 infected, had higher viral load set-point and slower antibody avidity maturati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f803a5dcb4d0cf82b2212b2865dc7dcb
http://europepmc.org/articles/PMC5576519
http://europepmc.org/articles/PMC5576519
Autor:
Carolyn Williamson, Philippe Selhorst, Sherazaan D. Ismail, Carina. Combrinck, Melissa-Rose Abrahams, Miguel Lacerda, Quarraisha Abdool Karim, Salim S. Abdool Karim, Nonkululeko. Ndabambi, Nigel Garrett, Natasha Samsunder
The viral genotype has been shown to play an important role in HIV pathogenesis following transmission. However, the viral phenotypic properties that contribute to disease progression remain unclear. Most studies have been limited to the evaluation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399bff03d4beef106274006a2e7f7510
https://europepmc.org/articles/PMC5375681/
https://europepmc.org/articles/PMC5375681/
Autor:
David Matten, Frederick A. Matsen, Sorachai Nitayaphan, Colin Anthony, Christopher Warth, Gordon Botha, Melissa-Rose Abrahams, Peter B. Gilbert, Merlin L. Robb, Hannah Kibuuka, Craig A. Magaret, Leigh Anne Eller, Carolyn Williamson, Sodsai Tovanabutra, Lindsay N. Carpp, Paul T. Edlefsen, Simon A. Travers, Yuanyuan Zhang, Jan P.L. Labuschagne, Morgane Rolland, Denis Chopera, Ted Holzman, Roux-Cil Ferreira, Erika Rudnicki, Fred Sawe, Raabya Rossenkhan, Yunda Huang, Nonkululeko. Ndabambi, Murray Logan
Publikováno v:
Viruses, Vol 11, Iss 7, p 607 (2019)
Viruses
Volume 11
Issue 7
Viruses
Volume 11
Issue 7
Knowledge of the time of HIV-1 infection and the multiplicity of viruses that establish HIV-1 infection is crucial for the in-depth analysis of clinical prevention efficacy trial outcomes. Better estimation methods would improve the ability to charac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e90c952ab2c1530841b83d0223a0f34
https://doi.org/10.3390/v11070607
https://doi.org/10.3390/v11070607
Autor:
Dennis R. Burton, Julie. Rouelle, Daniel J. Sheward, M. Gordon Joyce, Andrew B. Ward, Peter D. Kwong, Constantinos Kurt Wibmer, Carolyn Williamson, Lynn Morris, Nonkululeko. Ndabambi, Jason Gorman, Ashley. Smira, James E. Robinson, Penny L. Moore, Jinal N. Bhiman, Debra Holton Elliott, Aliaksandr Druz, John R. Mascola, Gabriel Ozorowski, Mark Connors, Salim S. Abdool Karim, Mangai Asokan
Publikováno v:
PLoS Pathogens, Vol 13, Iss 1, p e1006074 (2017)
PLoS Pathogens
PLoS Pathogens
A comprehensive understanding of the regions on HIV-1 envelope trimers targeted by broadly neutralizing antibodies may contribute to rational design of an HIV-1 vaccine. We previously identified a participant in the CAPRISA cohort, CAP248, who develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f73debcc33944351178a8177d8137fdc
http://europepmc.org/articles/PMC5226681?pdf=render
http://europepmc.org/articles/PMC5226681?pdf=render
Autor:
David Matten, Denis Chopera, Clive M. Gray, Quarraisha Abdool Karim, Carolyn Williamson, Nonkululeko. Ndabambi, Roman Ntale, Salim S. Abdool Karim, Nigel Garrett
Publikováno v:
AIDS (London, England). 31(2)
OBJECTIVE HIV-1 escape from cytotoxic T-lymphocytes results in the accumulation of human leucocyte antigen (HLA)-associated mutations in the viral genome. To understand the contribution of early escape to disease progression, this study investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c99ab56e75b821ba7992d8a63e43d4a
https://pubmed.ncbi.nlm.nih.gov/27755110
https://pubmed.ncbi.nlm.nih.gov/27755110
Autor:
Sarah Goodier, Eric Martin, Xiaomei T. Kuang, Quarraisha Abdool Karim, Zabrina L. Brumme, Saleha Omarjee, Vivek Naranbhai, Salim S. Abdool Karim, Philip Mwimanzi, Nonkululeko. Ndabambi, Denis Chopera, Mark A. Brockman, Carolyn Williamson, Thumbi Ndung'u, Jaclyn K. Mann
Publikováno v:
PLoS One
PLoS ONE, Vol 8, Iss 8, p e71758 (2013)
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e71758 (2013)
PLoS ONE
BACKGROUND: Use of antiretroviral-based microbicides for HIV-1 prophylaxis could introduce a transmission barrier that inadvertently facilitates the selection of fitter viral variants among incident infections. To investigate this, we assessed the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7847ee84a7d0c2177f42551e19d1404
http://hdl.handle.net/11427/16229
http://hdl.handle.net/11427/16229